Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela R Thomason

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Hospital Pharmacy|May 6, 2022
Potential Drug Interactions Between Cannabinoids and Its Derivatives and Oral AnticoagulantsMcKenzie Paduch, Angela R Thomason
Journal of the American Pharmacists Association : Japha|July 11, 2009
Pharmacists' advancing roles in drug and disease management: a review of states' legislationAlicia G McKnight, Angela R Thomason
Pharmacotherapy|October 4, 2012
Vilazodone for the treatment of major depressive disorderMaryam Iranikhah, Terri M Wensel, Angela R Thomason
Hospital Pharmacy|December 6, 2014
Recurrent venous thromboembolism in a patient with heterozygous factor v leiden mutationC Whitney White, Angela R Thomason, Valerie Prince
The Senior Care Pharmacist|March 23, 2023
Geriatric Pharmacotherapy Case Series: Potential Drug Interactions With Antiplatelet Medications and Cannabidiol-A Focus on P2Y12 InhibitorsStephen A Brown, Katie Boyd, Angela R Thomason
Journal of Christian Nursing : a Quarterly Publication of Nurses Christian Fellowship|June 10, 2020
Faith Integration in the Development of an Interprofessional Education Faculty FellowshipRobert W Hensarling, Lora Shelton, Angela R Thomason
Hospital Pharmacy|November 3, 2016
Role of Novel Oral Anticoagulants in the Treatment of Antiphospholipid SyndromeC Whitney White, Angela R Thomason, Katie Boyd
Journal of Thrombosis and Thrombolysis|October 14, 2016
The use of direct oral anticoagulants in inherited thrombophiliaJessica W Skelley, C Whitney White, Angela R Thomason
The Senior Care Pharmacist|March 2, 2019
Extended-Duration Use of Direct Oral Anticoagulants to Prevent VTE in Acutely III Medical PatientsJessica W Skelley, Angela R Thomason, Lauren N Hammond
P & T : a Peer-Reviewed Journal for Formulary Management|February 2, 2018
Betrixaban (Bevyxxa): A Direct-Acting Oral Anticoagulant Factor Xa InhibitorJessica W Skelley, Angela R Thomason, Jeffery C Nolen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Hospital Pharmacy|May 6, 2022
Potential Drug Interactions Between Cannabinoids and Its Derivatives and Oral AnticoagulantsMcKenzie Paduch, Angela R Thomason
Journal of the American Pharmacists Association : Japha|July 11, 2009
Pharmacists' advancing roles in drug and disease management: a review of states' legislationAlicia G McKnight, Angela R Thomason
Pharmacotherapy|October 4, 2012
Vilazodone for the treatment of major depressive disorderMaryam Iranikhah, Terri M Wensel, Angela R Thomason
Hospital Pharmacy|December 6, 2014
Recurrent venous thromboembolism in a patient with heterozygous factor v leiden mutationC Whitney White, Angela R Thomason, Valerie Prince
The Senior Care Pharmacist|March 23, 2023
Geriatric Pharmacotherapy Case Series: Potential Drug Interactions With Antiplatelet Medications and Cannabidiol-A Focus on P2Y12 InhibitorsStephen A Brown, Katie Boyd, Angela R Thomason
Journal of Christian Nursing : a Quarterly Publication of Nurses Christian Fellowship|June 10, 2020
Faith Integration in the Development of an Interprofessional Education Faculty FellowshipRobert W Hensarling, Lora Shelton, Angela R Thomason
Hospital Pharmacy|November 3, 2016
Role of Novel Oral Anticoagulants in the Treatment of Antiphospholipid SyndromeC Whitney White, Angela R Thomason, Katie Boyd
Journal of Thrombosis and Thrombolysis|October 14, 2016
The use of direct oral anticoagulants in inherited thrombophiliaJessica W Skelley, C Whitney White, Angela R Thomason
The Senior Care Pharmacist|March 2, 2019
Extended-Duration Use of Direct Oral Anticoagulants to Prevent VTE in Acutely III Medical PatientsJessica W Skelley, Angela R Thomason, Lauren N Hammond
P & T : a Peer-Reviewed Journal for Formulary Management|February 2, 2018
Betrixaban (Bevyxxa): A Direct-Acting Oral Anticoagulant Factor Xa InhibitorJessica W Skelley, Angela R Thomason, Jeffery C Nolen, et al.
Pageof 2